Neuraxis (NRXS) Director Aharon Gil Receives Stock Awards

What Happened

• Aharon Gil, a director of Neuraxis, reported multiple acquisitions (transaction code A) of common stock. The most significant was a director compensation grant of 43,930 shares on 2026-08-13 at $6.28 per share, valued at $275,880. The filing also reports dividend-related issuances dated 2026-07-29 that resulted in shares being issued in connection with accrued Series B preferred dividends.

Key Details

• Transaction dates and amounts:
  • 2026-08-13: 43,930 shares acquired at $6.28 — total value $275,880 (footnote F2: issued as compensation for services as independent director).
  • 2026-07-29: filings list 2,226 and 40,068 shares associated with dividend/conversion activity (footnote F1 clarifies the reporting person received 2,226 shares; 40,068 shares relate to Rosalind Master Fund L.P.).
• Shares owned after the transactions: not reported in the Form 4.
• Footnotes of note:
  • F1: The 07-29 issuances relate to conversion of accrued 8.5% cumulative dividends on Series B Preferred Stock (shares calculated by dividing accrued dividends by $2.38).
  • F2: The 08-13 shares were compensation for director services.
  • F3: Reporting person disclaims beneficial ownership except to extent of pecuniary interest.
• Timeliness: The report covers transactions through 2026-08-13 and was filed 2026-08-17 — the Form 4 appears to have been filed within the required two business days.

Context

• These were awards/dividend-conversion issuances (not open-market purchases or sales). Awards and dividend conversions are routine corporate actions or compensation and do not necessarily indicate the insider bought or sold shares in the market. The $275,880 director award is the clearest dollar-value item in this filing.